SEC Form 4 · accession 0001246360-17-001165
DENTSPLY SIRONA Inc. · XRAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Bret W Wise
Officer — Executive Chairman, Board · Director
Period of report
Feb 24, 2017
Accepted (ET)
Mar 2, 2017 · 4:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818479
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 24, 2017 | M | 22,829 | $0.00 | A | 142,121 | D | |
| Common StockF2 | Feb 24, 2017 | M | 29,563 | $0.00 | A | 171,684 | D | |
| Common StockF5 | Feb 24, 2017 | F | 28,254 | $62.79 | D | 143,430 | D | |
| Common Stock | Feb 28, 2017 | M | 14,275 | $45.15 | A | 157,705 | D | |
| Common StockF8 | Feb 28, 2017 | S | 14,275 | $63.8496 | D | 143,430 | D | |
| Common Stock | Mar 1, 2017 | M | 132,625 | $45.15 | A | 276,055 | D | |
| Common StockF9 | Mar 1, 2017 | S | 132,625 | $64.2005 | D | 143,430 | D | |
| Common Stock | holding | — | — | — | 16,185 | I | Bret W. Wise Deed of Trust | |
| Common Stock | holding | — | — | — | 10,561 | I | by Spouse | |
| Common Stock | holding | — | — | — | 8,639 | I | Wise GRAT 2 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RSU (Restricted Stock Unit)F1,F3 | — | Feb 24, 2017 | M | 22,829 | D | Feb 24, 2017 | Feb 24, 2017 | Common Stock | 22,829 | 37,316 | D |
| PRSU (Performance Measured Restricted Stock Unit)F2,F4 | — | Feb 24, 2017 | M | 29,563 | D | Feb 24, 2017 | Feb 24, 2017 | Common Stock | 29,563 | 76,424 | D |
| Stock OptionF6 | $45.15 | Feb 28, 2017 | M | 14,275 | D | — | Dec 10, 2017 | Common Stock | 14,275 | 132,625 | D |
| Stock OptionF6 | $45.15 | Mar 1, 2017 | M | 132,625 | D | — | Dec 10, 2017 | Common Stock | 132,625 | 0 | D |
Explanation of responses
- F1Comprised of twenty-two thousand four hundred sixty-four (22,464) vested RSUs plus three hundred sixty-five (365) RSUs accrued through dividend equivalent rights, each as previously reported in this Table II.
- F2Comprised of twenty-nine thousand and ninety (29,090) vested Performance Restricted Stock Units (PRSUs) plus four hundred seventy-three (473) DERs accrued through dividend equivalent rights, each as previously reported in this Table II.
- F3Restricted Stock Units (RSUs) convert into Common Stock on a one-for-one basis for no additional consideration.
- F4Performance Restricted Stock Units (PRSUs) convert into Common Stock on a one-for-one basis for no additional consideration.
- F5Shares withheld to cover taxes related to the vesting of the reporting person's RSUs and PRSUs.
- F6This option is fully vested and exercisable.
- F7This sale was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person.
- F8The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.80 to $63.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F9The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.73 to $64.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.